Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Quote: Check out the tweet in the last 24 hours from Rep. Andy Harris, MD of Maryland, who is one of three people on the DMC reviewing RLF-100, and who has direct links to the White House. Regarding Operation Warp Speed, he said, "...this ultimate public private partnership has our nation on the cusp of a medical miracle, and once approved, millions of doses will be available immediately."~The Whale>>>>>>>>
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Data monitoring committees act best in an advisory capacity, making recommendations to the group responsible for running the trial, possibly with recourse to an arbiter if this group disagrees with its recommendations. Deciding that a trial should be stopped early is never easy because of the range of issues and responsibilities that must be taken into consideration. Good research governance means that the organisers of trials need to give serious and early consideration to arrangements for monitoring accumulating data particularly the constitution, roles, responsibilities, and procedures of data monitoring committees.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516093/